HIV-1 Tat-driven Glutamate Dysregulation: Implications for Cognitive Impairment in HAND

Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990–1998. Neurology. 2001;56(2):257–60.

Article  CAS  PubMed  Google Scholar 

Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder–pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234–48.

Article  PubMed  PubMed Central  Google Scholar 

Cross S, Onen N, Gase A, Overton ET, Ances BM. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol. 2013;8(5):1114–22.

Article  PubMed  PubMed Central  Google Scholar 

Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol. 2004;10(6):350–7.

Article  PubMed  Google Scholar 

Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.

Article  CAS  PubMed  Google Scholar 

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cysique LA, Maruff P, Brew BJ. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology. 2006;66(9):1447–50.

Article  PubMed  Google Scholar 

Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci. 2006;26(4):1098–106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahimy E, Li FY, Hagberg L, Fuchs D, Robertson K, Meyerhoff DJ, et al. Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy. J Infect Dis. 2017;215(7):1132–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

An SF, Giometto B, Scaravilli F. HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol. 1996;40(4):611–7.

Article  CAS  PubMed  Google Scholar 

An SF, Groves M, Gray F, Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol. 1999;58(11):1156–62.

Article  CAS  PubMed  Google Scholar 

Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, et al. Neuropathology of early HIV-1 infection. Brain Pathol. 1996;6(1):1–15.

Article  CAS  PubMed  Google Scholar 

An SF, Scaravilli F. Early HIV-1 infection of the central nervous system. Arch Anat Cytol Pathol. 1997;45(2–3):94–105.

CAS  PubMed  Google Scholar 

Gelman BB. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol. 1993;34(1):65–70.

Article  CAS  PubMed  Google Scholar 

Kure K, Lyman WD, Weidenheim KM, Dickson DW. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol. 1990;136(5):1085–92.

CAS  PubMed  PubMed Central  Google Scholar 

Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol. 1990;80(4):393–400.

Article  CAS  PubMed  Google Scholar 

Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol. 1992;32(3):321–9.

Article  CAS  PubMed  Google Scholar 

Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992;42(9):1736–9.

Article  CAS  PubMed  Google Scholar 

Palmer DL, Hjelle BL, Wiley CA, Allen S, Wachsman W, Mills RG, et al. HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am J Med. 1994;97(3):289–95.

Article  CAS  PubMed  Google Scholar 

Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206(2):275–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Churchill MJ, Gorry PR, Cowley D, Lal L, Sonza S, Purcell DF, et al. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol. 2006;12(2):146–52.

Article  PubMed  Google Scholar 

Donoso M, D’Amico D, Valdebenito S, Hernandez CA, Prideaux B, Eugenin EA. Identification, quantification, and characterization of HIV-1 Reservoirs in the human brain. Cells. 2022;11(15).

Ko A, Kang G, Hattler JB, Galadima HI, Zhang J, Li Q, et al. Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. J Neuroimmune Pharmacol. 2019;14(1):110–9.

Article  PubMed  Google Scholar 

Sharpless N, Gilbert D, Vandercam B, Zhou JM, Verdin E, Ronnett G, et al. The restricted nature of HIV-1 tropism for cultured neural cells. Virology. 1992;191(2):813–25.

Article  CAS  PubMed  Google Scholar 

Tang Y, Chaillon A, Gianella S, Wong LM, Li D, Simermeyer TL et al. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J Clin Invest. 2023;133(12).

Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, et al. Microglial Cells: The Main HIV-1 Reservoir in the Brain. Front Cell Infect Microbiol. 2019;9:362.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol. 2009;66(2):253–8.

Article  PubMed  Google Scholar 

Fujimura RK, Bockstahler LE. Polymerase chain reaction method for determining ratios of human immunodeficiency virus proviral DNA to cellular genomic DNA in brain tissues of HIV-infected patients. J Virol Methods. 1995;55(3):309–25.

Article  CAS  PubMed  Google Scholar 

Fujimura RK, Goodkin K, Petito CK, Douyon R, Feaster DJ, Concha M, et al. HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16(3):146–52.

Article  CAS  PubMed  Google Scholar 

Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, et al. Distribution of brain HIV load in AIDS. Brain Pathol. 1998;8(2):277–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imamichi H, Smith M, Adelsberger JW, Izumi T, Scrimieri F, Sherman BT, et al. Defective HIV-1 proviruses produce viral proteins. Proc Natl Acad Sci U S A. 2020;117(7):3704–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gbadamosi SO, Trepka MJ, Dawit R, Jebai R, Sheehan DM. A Systematic Review and Meta-analysis to Estimate the Time from HIV Infection to Diagnosis for People with HIV. AIDS Rev. 2022;24(1):32–40.

Comments (0)

No login
gif